Skip to main content

Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device

Submitted by kassing on Tue, 08/27/2024 - 19:23
  • Read more about Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device

Lysosomal Acid Lipase (LAL) Deficiency Registry

Submitted by kassing on Tue, 08/27/2024 - 19:22
  • Read more about Lysosomal Acid Lipase (LAL) Deficiency Registry

A Study of NPX887 for Participants With Solid Tumors Known to Express HHLA2/B7-H7

Submitted by kassing on Thu, 08/22/2024 - 14:06
  • Read more about A Study of NPX887 for Participants With Solid Tumors Known to Express HHLA2/B7-H7

Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)

Submitted by kassing on Thu, 08/22/2024 - 14:06
  • Read more about Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2)

Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)

Submitted by kassing on Thu, 08/22/2024 - 14:06
  • Read more about Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)

A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Submitted by kassing on Thu, 08/22/2024 - 14:06
  • Read more about A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Submitted by kassing on Thu, 08/22/2024 - 14:06
  • Read more about Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE)

Submitted by kassing on Thu, 08/22/2024 - 14:06
  • Read more about Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE)

Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors

Submitted by kassing on Thu, 08/22/2024 - 14:05
  • Read more about Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors

Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

Submitted by kassing on Thu, 08/22/2024 - 14:05
  • Read more about Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • …
  • Next page Next
  • Last page Last
Subscribe to